DRUG-PATHWAY

DRUGs and PATHWAYs

PATHWAY_NAME	REACTOME_ID	KEGG_ID	DRUG_NAME	PUBCHEM_CID	Datasource
Type I diabetes mellitus	R-HSA-5683209	map04940	cefalotin	6890	drug-path
PPAR signaling pathway	R-HSA-168638	map03320	esculin	10219	drug-path
Alzheimer's disease	R-HSA-1643685	0	esculin	10219	drug-path
Olfactory transduction	R-HSA-9751605	map04740	esculin	10219	drug-path
Systemic lupus erythematosus	R-HSA-977105	map05322	esculin	10219	drug-path
Vascular smooth muscle contraction	R-HSA-445355	map04270	esculin	10219	drug-path
Homologous recombination	R-HSA-5685942	map03440	esculin	10219	drug-path
Shigellosis	0	map05131	esculin	10219	drug-path
Insulin signaling pathway	R-HSA-74752	map04910	esculin	10219	drug-path
Adherens junction	R-HSA-451386	map04520	esculin	10219	drug-path
Pathogenic Escherichia coli infection	R-HSA-9609646	map05130	esculin	10219	drug-path
Regulation of actin cytoskeleton	R-HSA-392751	map04810	esculin	10219	drug-path
Cytokine-cytokine receptor interaction	R-HSA-6788467	map04060	esculin	10219	drug-path
Endometrial cancer	R-HSA-2077421	map05213	esculin	10219	drug-path
Hematopoietic cell lineage	R-HSA-173752	map04640	fenbendazole	10237	drug-path
Systemic lupus erythematosus	R-HSA-977105	map05322	fenbendazole	10237	drug-path
Long-term potentiation	R-HSA-9620244	map04720	fenbendazole	10237	drug-path
ECM-receptor interaction	R-HSA-373711	map04512	fenbendazole	10237	drug-path
Jak-STAT signaling pathway	R-HSA-168638	map04630	fenbendazole	10237	drug-path
Complement and coagulation cascades	R-HSA-114591	map04610	fenbendazole	10237	drug-path